After earning a Doctorate of Pharmacy in the University of Montpellier, France, in 1989, Valérie joined the French affiliate of what is now sanofi, where she held positions of increasing responsibilities in Regulatory Affairs. After 15 years of experience in the field of European regulatory affairs, she joined the Access to Medicines department, in the Corporate Social Responsibility Division of Sanofi in 2005. During more than 10 years, Valerie has developed a recognized expertise and network in the area of access to healthcare and quality of medicines in developing countries. In 2017, Valerie has been appointed Head of the Sanofi Espoir Foundation, which proposes, develops, implements partnerships and projects of general interest which reflect Sanofi’s commitments to contribute reducing health inequalities and which respond to humanitarian crisis to assure access to healthcare for the victims and displaced people.
From poverty and epidemics to wars and mass migrations, it is impossible to ignore the afflictions that demoralize the lives of millions of people, impeding their development potential and adding a huge financial burden to the economies of their countries. In a global context of interdependence, development challenges are an obvious shared priority now that insecurity and disease are constantly gaining ground, even in wealthy countries. Working with its partners, the Foundation develops prevention and access to care programs tailored to local realities. Committed to efficiency, it seeks to anticipate and understand so that it can act more effectively. Each project is designed to scale up and lead to economically sustainable health solutions, wherever the needs are felt. By virtue of the quality of the work carried out and the progress made in its areas of expertise, the Foundation is now widely recognized both by healthcare institutions and the countries that benefit from its programs. By virtue of the quality of the work carried out and the progress made in its areas of expertise, the Foundation is now widely recognized both by healthcare institutions and the countries that benefit from its programs.